The Hongkong and Shanghai Hotels (45) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
7 Jan, 2026Executive summary
Revenue rose 26–27% year-over-year to HK$10.3B–HK$10.99B, driven by The Peninsula London’s full-year contribution and strong residential sales.
Net loss of HK$943M was reported, mainly due to higher depreciation, increased financing charges, and property revaluation losses.
Underlying loss narrowed to HK$176M, reflecting operational recovery; no final dividend declared for 2024.
Financial position remains stable with net assets of HK$35.4B and net debt to total assets at 23%.
Focus remains on stabilizing new hotels, reducing borrowings, and growing profitability.
Financial highlights
Total group revenue rose 27% to HK$10.3B, including HK$3.5B from seven Peninsula London residences sold.
EBITDA increased 32% to HK$1.45B; net operating cash flow (ex-residences) was HK$523M.
Operating profit rose 31% to HK$760M; loss per share was HK$(0.57) compared to HK$0.09 last year.
Net external borrowings decreased 17% to HK$12.5B; significant net debt reduction of HK$2.5B.
Adjusted net assets per share at HK$24.01, down 4% year-over-year.
Outlook and guidance
Business outlook is stable with cautious optimism for 2025, supported by recovery in luxury tourism and improving long-haul leisure travel, especially in Hong Kong and Japan.
Peninsula Hong Kong started 2025 ahead of budget; Peninsula New York expects growth post-renovation.
Europe focus is on stabilizing new hotels in London and Istanbul, with Paris performing well.
Strong demand for residential apartments at The Repulse Bay.
Geopolitical tensions and global economic uncertainties remain a concern.
Latest events from The Hongkong and Shanghai Hotels
- Profitability restored in 2025 with robust revenue and EBITDA growth, supported by Vision 2035.45
H2 202518 Mar 2026 - Revenue surged on London sales, but higher costs and revaluation losses resulted in a net loss.45
H1 20242 Feb 2026 - Strong revenue and EBITDA growth, narrowed losses, and a positive outlook despite risks.45
H1 20256 Jan 2026